Form 4 for IMAX IMAX CORP
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001214659-24-004349 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-11 | 2024-03-07 | IMAX | PABLO CALAMERA | CTO, EVP | F - Tax | $16.80 | -12.3K | 42.5K | -22% | -$206.3K |
| D | 2024-03-11 | 2024-03-07 | IMAX | PABLO CALAMERA | CTO, EVP | A - Grant | $0.00 | +9,950 | 52.4K | +23% | $0 |
| DM | 2024-03-11 | 2024-03-07 | IMAX | PABLO CALAMERA | CTO, EVP | M - OptEx | $0.00 | +19.9K | 36.5K | +120% | $0 |
| DM | 2024-03-11 | 2024-03-07 | IMAX | PABLO CALAMERA | CTO, EVP | M - OptEx | $0.00 | -19.9K | 16.1K | -55% | $0 |
| D | 2024-03-11 | 2024-03-07 | IMAX | PABLO CALAMERA | CTO, EVP | A - Grant | $0.00 | +22.2K | 22.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2024-03-07 | F | D | 4,010 | $16.80 | 48,399 | D | — | — | (F4) Mr. Calamera is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance stock unit transactions. |
| 2 | Common | common shares | 2024-03-07 | A | A | 9,950 | $0.00 | 52,409 | D | — | — | (F3) Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2021. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period. |
| 3 | Common | common shares | 2024-03-07 | F | D | 8,269 | $16.80 | 42,459 | D | — | — | (F2) Mr. Calamera is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions. |
| 4 | Common | common shares | 2024-03-07 | M | A | 8,042 | $0.00 | 50,728 | D | — | — | (F1) Represents the conversion upon vesting of restricted share units into common shares. |
| 5 | Common | common shares | 2024-03-07 | M | A | 6,185 | $0.00 | 42,686 | D | — | — | (F1) Represents the conversion upon vesting of restricted share units into common shares. |
| 6 | Common | common shares | 2024-03-07 | M | A | 5,688 | $0.00 | 36,501 | D | — | — | (F1) Represents the conversion upon vesting of restricted share units into common shares. |
| 7 | Derivative | restricted share units | 2024-03-07 | M | D | 6,185 | $0.00 | 6,185 | D | $0.00 · — to — | 6,185 common shares | (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F11) This represents the number of restricted share units for this transaction only. Mr. Calamera's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 44,499 and 48,399, respectively. (F8) The restricted share units vest and will be converted to common shares in three equal installments on each of first three anniversaries of the grant date. |
| 8 | Derivative | restricted share units | 2024-03-07 | A | A | 22,228 | $0.00 | 22,228 | D | $0.00 · — to — | 22,228 common shares | (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F11) This represents the number of restricted share units for this transaction only. Mr. Calamera's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 44,499 and 48,399, respectively. (F10) The restricted share units vest and will be converted to common shares in three installments: 7,409 on each of March 7, 2025 and March 7, 2026 and 7,410 on March 2027. |
| 9 | Derivative | restricted share units | 2024-03-07 | M | D | 5,688 | $0.00 | 0 | D | $0.00 · — to — | 5,688 common shares | (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F11) This represents the number of restricted share units for this transaction only. Mr. Calamera's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 44,499 and 48,399, respectively. (F7) The restricted share units vest and will be converted to common shares in three installments: 5,686 on each of March 7, 2022 and March 7, 2023 and 5,688 on March 7, 2024. |
| 10 | Derivative | restricted share units | 2024-03-07 | M | D | 8,042 | $0.00 | 16,086 | D | $0.00 · — to — | 8,042 common shares | (F5) Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. (F1) Represents the conversion upon vesting of restricted share units into common shares. (F6) Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. (F11) This represents the number of restricted share units for this transaction only. Mr. Calamera's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 44,499 and 48,399, respectively. (F9) The restricted share units vest and will be converted to common shares in three installments: 8,042 on each of March 7, 2024 and March 7, 2025 and 8,044 on March 7, 2026. |